Search Results

You are looking at 41 - 50 of 55 items for :

  • "levofloxacin" x
Clear All

), ticarcillin/clavulanic acid (75/10 μg), tobramycin (10 μg), netilmicin (30 μg), cefepime (30 μg) cefotaxime (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg), ciprofloxacin (5 μg), levofloxacin (5 μg), ofloxacin (5 μg), meropenem (10 μg), imipenem (10 μg

Restricted access

method according to recommendations of the Clinical and Laboratory Standards Institute (CLSI) [ 21 ]. The antibiotics tested were as follows: cefoxitin (30 μg), levofloxacin (10 μg), gentamicin (10 μg), amikacin (30 μg), cefotaxime (30 μg), tobramycin (10

Restricted access

antimicrobial agents, ampicillin/sulbactam (10/10 µg), meropenem (10 μg), gentamicin (10 μg), doxycycline (30 µg), ciprofloxacin (5 μg), co-trimoxazole (1.25/23.75 μg), cefepime (30 μg), ceftazidime (30 μg), and levofloxacin (30 μg) (Mast, UK). Results were

Restricted access

in this study included ceftazidime, colistin, levofloxacin, polymyxin B, aztreonam, ciprofloxacin, amikacin, cefepime, and piperacillin/tazobactam. In this study, MDR was considered as acquired non-susceptibility to at least one agent in three or more

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Yeliz Çetinkol, Cemal Sandalli, Mustafa Kerem Çalgin, Arzu Altunçekiç Yildirim, Esma Akyildiz, Esin Karaman and Ayşegül Çopur Çiçek

), gentamicin (GN), tobramycin, levofloxacin (LEV), ciprofloxacin (CIP), nitrofurantoin (F), tetracycline (TE), ertapenem (ETP), imipenem (IPM), and SXT antibiotic disks and the results were evaluated according to the CLSI guidelines [ 12

Restricted access
European Journal of Microbiology and Immunology
Authors: Isabel Stephany-Brassesco, Stefan Bereswill, Markus M. Heimesaat and Matthias F. Melzig

species, and Stenotrophomonas maltophilia are important causal agents [ 20 ]. In general, HAP should be treated with piperacillin–tazobactam, cefepime, levofloxacin, or a carbapenem. For the treatment of VAP, 3 groups of antibiotics should be considered

Open access

, levofloxacin, and moxifloxacin), aminoglycosides (gentamicin and tobramycin), glycopeptides (vancomycin and teicoplanin), the macrolide erythromycin, the lincosamide clindamycin, the streptogramin quinupristin, tetracycline, the glycylcycline tigecycline, the

Open access

peak), severe thrombocytopenia (8,000/μl), severe neutropenia (300/μl), anemia [hemoglobin (Hb) 6.6 g/dl], and hepatosplenomegaly. An empirical therapy with different combinations of broad-spectrum antibiotics (levofloxacin, ceftriaxone, meropenem

Restricted access

containing cefixime, cefuroxime axetil, cephalexin·H 2 O, ciprofloxacin HCl, levofloxacin, and metronidazole. In this article, the application of the transfer process is extended by seven products containing eight important drugs of different types

Open access

.1155/2016/2475067 4. Wagenlehner FM , Umeh O , Steenbergen J , Yuan G , Darouiche RO . Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary

Open access